AR (EC:1.1.1.21) is the first rate-limiting enzyme involved inthe polyol pathway and plays a prominent role in explaining the pathogenesisof complications in patients with DM.19 AR catalyzes the reduction of excess glucose to sorbitol, convertingnicotinamide adenine dinucleotide phosphate (NADPH) to NADP+. Here, AR is linked to diabetes mellitus.